Total Payments
$17,027
2024 Payments
$1,077
Companies
21
Transactions
113
Medicare Patients
2,117
Medicare Billing
$56,182
Payment Breakdown by Category
Consulting$10,520 (61.8%)
Food & Beverage$5,059 (29.7%)
Travel$1,418 (8.3%)
Gifts$30.00 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,520 | 3 | 61.8% |
| Food and Beverage | $5,059 | 107 | 29.7% |
| Travel and Lodging | $1,418 | 2 | 8.3% |
| Gift | $30.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Respiratory Technologies, Inc. | $6,396 | 3 | $0 (2017) |
| GENZYME CORPORATION | $5,519 | 18 | $0 (2024) |
| Philips Electronics North America Corporation | $2,119 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $893.21 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $859.48 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $434.75 | 12 | $0 (2024) |
| AstraZeneca UK Limited | $145.53 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.43 | 3 | $0 (2023) |
| Mylan Specialty L.P. | $110.06 | 5 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $66.08 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,077 | 36 | Regeneron Healthcare Solutions, Inc. ($314.14) |
| 2023 | $6,062 | 32 | GENZYME CORPORATION ($5,172) |
| 2022 | $455.93 | 8 | GENZYME CORPORATION ($167.44) |
| 2021 | $497.61 | 7 | AstraZeneca Pharmaceuticals LP ($241.99) |
| 2020 | $96.08 | 5 | Sunovion Pharmaceuticals Inc. ($66.08) |
| 2019 | $650.34 | 9 | Philips Electronics North America Corporation ($528.48) |
| 2018 | $1,701 | 7 | Philips Electronics North America Corporation ($1,576) |
| 2017 | $6,488 | 9 | Respiratory Technologies, Inc. ($6,396) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Mylan Specialty L.P. | TOBI PODHALER (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Aminoglycosides | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Pulmonology | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $109.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/20/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $112.90 | General |
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Mylan Specialty L.P. | TOBI PODHALER (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Aminoglycosides | ||||||
| 04/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 463 | 597 | $47,009 | $11,549 |
| 2022 | 8 | 498 | 656 | $53,490 | $13,457 |
| 2021 | 8 | 549 | 673 | $60,058 | $15,821 |
| 2020 | 10 | 607 | 740 | $60,215 | $15,355 |
Total Patients
2,117
Total Services
2,666
Medicare Billing
$56,182
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 45 | $12,894 | $3,416 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 20 | 22 | $8,956 | $2,509 | 28.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 75 | 99 | $6,138 | $1,607 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 25 | $4,696 | $1,290 | 27.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 110 | 137 | $3,425 | $888.30 | 25.9% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 95 | 134 | $4,690 | $809.26 | 17.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 64 | 81 | $4,374 | $595.30 | 13.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 53 | 54 | $1,836 | $435.16 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 32 | 40 | $11,420 | $2,961 | 25.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 23 | $9,365 | $2,638 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 37 | 50 | $10,526 | $2,619 | 24.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 76 | 112 | $6,944 | $2,008 | 28.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 110 | 147 | $3,675 | $1,052 | 28.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 102 | 144 | $5,040 | $938.07 | 18.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 72 | 88 | $4,752 | $735.59 | 15.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 52 | 52 | $1,768 | $505.10 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 48 | 63 | $17,646 | $5,019 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 60 | 75 | $15,314 | $3,926 | 25.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 90 | 113 | $6,962 | $1,993 | 28.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 16 | $6,724 | $1,931 | 28.7% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 123 | 145 | $3,595 | $1,027 | 28.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 118 | 156 | $5,194 | $997.18 | 19.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 53 | 59 | $3,074 | $493.00 | 16.0% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 46 | 46 | $1,549 | $435.16 | 28.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 44 | 67 | $13,904 | $4,197 | 30.2% |
About Dr. Nereida Parada, MD
Dr. Nereida Parada, MD is a Pulmonary Disease healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376636175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nereida Parada, MD has received a total of $17,027 in payments from pharmaceutical and medical device companies, with $1,077 received in 2024. These payments were reported across 113 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($10,520).
As a Medicare-enrolled provider, Parada has provided services to 2,117 Medicare beneficiaries, totaling 2,666 services with total Medicare billing of $56,182. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location New Orleans, LA
- Active Since 10/02/2006
- Last Updated 08/19/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1376636175
Products in Payments
- DUPIXENT (Biological) $5,476
- CoughAssist 2 (Device) $1,041
- NUCALA (Biological) $598.72
- Respiratoriy Care Undiv (Device) $423.74
- Trilogy 100 (Device) $275.99
- inCourage (Device) $252.49
- TEZSPIRE (Biological) $210.10
- AIRSUPRA (Drug) $198.68
- OFEV (Drug) $140.43
- FASENRA (Biological) $137.28
- BREZTRI (Drug) $124.97
- TRELEGY ELLIPTA (Drug) $114.56
- BEVESPI AEROSPHERE (Drug) $94.80
- CoughAssist (Device) $83.32
- YUPELRI (Drug) $61.69
- LONHALA MAGNAIR (Drug) $50.72
- TOBI PODHALER (Drug) $48.37
- Arikayce (Drug) $36.62
- Xolair (Biological) $33.12
- S&RC Und (Device) $27.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in New Orleans
Dr. Joseph Lasky, Md, MD
Pulmonary Disease — Payments: $549,698
Pulmonary Disease $549,698
Juzar Ali, Md.,Frcp., Fccp(C), MD.,FRCP., FCCP(C)
Pulmonary Disease — Payments: $233,193
Pulmonary Disease $233,193
Dr. Ramsy Abdelghani, M.d, M.D
Pulmonary Disease — Payments: $222,746
Pulmonary Disease $222,746
Dr. William Emory, Md, MD
Pulmonary Disease — Payments: $35,923
Pulmonary Disease $35,923
Dr. Ross Klingsberg, M.d, M.D
Pulmonary Disease — Payments: $11,314
Pulmonary Disease $11,314
Dr. Steve Nelson, Md, MD
Pulmonary Disease — Payments: $8,881
Pulmonary Disease $8,881